weekly basal - Robuta Search

https://www.healio.com/news/endocrinology/20260327/fda-approves-onceweekly-basal-insulin-for-adults-with-type-2-diabetes FDA approves once-weekly basal insulin for type 2 diabetes Mar 27, 2026 - The FDA approved a once-weekly, long-acting basal insulin for adults with type 2 diabetes as an alternative to daily basal insulin, Novo Nordisk announced.... type 2 diabetes fda approves weekly basal insulin https://www.prnewswire.com/news-releases/fda-approves-novo-nordisks-awiqli-the-first-and-only-once-weekly-basal-insulin-treatment-for-adults-with-type-2-diabetes-302726839.html FDA approves Novo Nordisk's Awiqli®, the first and only once-weekly basal insulin treatment for... Mar 26, 2026 - /PRNewswire/ -- Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved Awiqli® (insulin icodec-abae) injection 700... fda approves novo nordisk weekly basal insulin treatment first https://idf.org/what-we-do/education/idf-imne-webinar-on-implementation-of-once-weekly-basal-insulins/ IDF-IMNE webinar on implementation of once-weekly basal insulins - International Diabetes Federation Feb 3, 2025 - Designed for healthcare professionals, this webinar provides the practical guidance needed to implement once-weekly basal insulins. weekly basal international diabetes idf webinar implementation https://www.webmd.com/drugs/updates/awiqli-once-weekly-long-acting-basal-insulin-for-adults-with-type-2-diabetes Awiqli: FDA Approves First and Only Once-Weekly Long-Acting Basal Insulin for Adults With Type 2... The FDA has approved Awiqli, the first once‑weekly long‑acting basal insulin, for adults with type 2 diabetes, which offers convenient weekly dosing compared... fda approves first long acting basal insulin type 2 weekly